Looking for the next big breakthrough in CAR-T, Mike Gilman debuts Obsidian with $49.5M round – Endpoints News
Endpoints News |
Looking for the next big breakthrough in CAR–T, Mike Gilman debuts Obsidian with $49.5M round
Endpoints News Building off some research work he'd done in the lab for years, the crew has been working with what he calls destabilizing domains, mutants which can be encoded in a “synthetic biologic cassette,” packaged in a vector and dispatched to tinker with an … Obsidian launches with $49.5 million to fine tune cellular and gene therapies Biogen vet launches cancer drug startup with $50M from GV, others Obsidian Therapeutics Announces $49.5 Million Series A Financing to Develop Controllable Cell and Gene Therapy … |
